The vitamin A supplementation in COVID-19 patients
Phase 3
- Conditions
- Condition 1: Corona-virus. Condition 2: Cardiovascular disease.Coronavirus infection, unspecifiedAtherosclerotic heart disease of native coronary arteryB34.2I25.1
- Registration Number
- IRCT20200826048535N1
- Lead Sponsor
- Tehran Heart Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 75
Inclusion Criteria
The individual age between 30-70 year
The people with history of cardiovascular disease
The COVID-19 people with PCR positive or Chest CT scan with ground glass viral pattern
Exclusion Criteria
The end stage renal disease people or GFR<60
The people with liver disease
Intubate or end stage disease people
The people with consumption vitamin A supplement
The patients that suffering cancer disease or chemo-radio therapy
The hemodialysis patient GFR<20
The people infected to bacterial or fungal disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method